Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct
- 1 May 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 51 (5), 1352-1357
- https://doi.org/10.1161/hypertensionaha.107.108506
Abstract
We sought to define the contribution of each of the 2 kinin receptors (bradykinin 1 receptor [B 1 R] and bradykinin 2 receptor [B 2 R]) to the cardioprotection of angiotensin-converting enzyme (ACE) inhibition after acute myocardial infarct. Wild-type mice and gene knockout mice missing either B 1 R or B 2 R were submitted to coronary ligation with or without concurrent ACE inhibition and had evaluation of left ventricular systolic capacity by assessment of fractional shortening (FS). Baseline FS was similar in all of the animals and remained unchanged in sham-operated ones. At 3 weeks after myocardial infarct, in the wild-type group there was a 27% reduction of FS ( P 1 R −/− groups the FS was reduced by 24% and was no different (at 28%) with ACE inhibition; in the B 2 R −/− groups, however, the FS was decreased by 39% and with ACE inhibition was decreased further by 52%. Analysis of bradykinin receptor gene expression in hearts showed that when one receptor was missing, the other became significantly upregulated; but the B 1 R remained highly overexpressed in the B 2 R −/− mice throughout, whereas the overexpressed B 2 R became significantly suppressed in the B 1 R −/− mice in a manner quantitatively and directionally similar to that of wild-type mice. We conclude that both bradykinin receptors contribute to the cardioprotective bradykinin-mediated effect of ACE inhibition, not only the B 2 R as believed previously; but, whereas with potentiated bradykinin in the absence of B 1 R, the upregulation of B 2 R is simply insufficient to provide full cardioprotection, in the absence of B 2 R, the upregulated B 1 R actually seems to inflict further tissue damage.Keywords
This publication has 26 references indexed in Scilit:
- Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinasesArchives of Physiology and Biochemistry, 2006
- Role of the B 1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial InfarctionHypertension, 2005
- Mechanisms Mediating the Vasoactive Effects of the B 1 Receptors of BradykininHypertension, 2003
- Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykininCurrent Opinion in Endocrinology, Diabetes and Obesity, 2002
- Fatty Acid Oxidation in the Reperfused Ischemic HeartThe American Journal of the Medical Sciences, 1999
- Salt-Sensitive Hypertension in Bradykinin B2Receptor Knockout MiceBiochemical and Biophysical Research Communications, 1996
- Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart.Hypertension, 1994
- Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.Hypertension, 1994
- Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.Hypertension, 1986
- Hypertensive effect of a bradykinin antagonist in normotensive rats.Hypertension, 1986